AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metdot 1000mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Ablus Pharma

Salt Composition

Metformin (1000mg)

Overview Metdot 1000mg Tablet SR

DiaMet 1000mg Extended-Release tablets manage type 2 diabetes mellitus by regulating blood glucose, mitigating associated complications. This medication also treats Polycystic Ovary Syndrome (PCOS) in women. For optimal absorption and to minimize gastrointestinal distress (nausea, abdominal pain), consume DiaMet with food. Consistent daily dosing is crucial for effectiveness; discontinue only under physician guidance. Maintaining a healthy lifestyle—including diet and exercise as prescribed—is integral to diabetes management. Common side effects include diarrhea, nausea, vomiting, gas, fatigue, indigestion, stomach upset, headache, and decreased appetite. Concurrent use with other diabetes medications, alcohol, or missed meals may cause hypoglycemia (low blood sugar). Regular blood glucose monitoring is essential. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require physician consultation. Kidney function will be assessed before prescription. Limit alcohol consumption to reduce potential side effects.

Uses of Metdot 1000mg Tablet SR

Management of type 2 diabetes and polycystic ovary syndrome

Major Benefits of Metdot 1000mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the 1000mg Metdot SR tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

Common Side effects of Metdot 1000mg Tablet SR:

  • Diarrhea
  • Headache
  • Vomiting
  • Nausea
  • Flatulence
  • Abdominal discomfort
  • Weakness

How to use Metdot 1000mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metdot 1000mg SR tablet should be taken with a meal.

How Metdot 1000mg Tablet SR works:

Glucovance 1000mg Extended-Release tablets are a biguanide-class antidiabetic drug. Their mechanism involves reducing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Metdot 1000mg Tablet SR and alcohol is not advisable due to safety concerns.

PregnancyPregnancySAFE IF PRESCRIBED

Extended-release Metdot 1000mg tablets are typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or absent negative impacts on fetal development; nevertheless, clinical data from human trials are scarce.

Breast feedingBreast feedingCAUTION

Extended-release Metdot 1000mg tablets require careful consideration while breastfeeding. Mothers should discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Metdot 1000mg Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Metdot 1000mg Tablet SR is contraindicated in patients exhibiting severe kidney disease.

LiverLiverUNSAFE

Extended-release Metdot 1000mg tablets are contraindicated in individuals with hepatic impairment and should be omitted. Seek medical advice.

What if you forget to take Metdot 1000mg Tablet SR :

Should you forget to take your Metdot 1000mg Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metdot 1000mg Tablet SR

LabelValue
Type of Compound Guanidine-based hypoglycemic agent
Addictive None.
Medication Classification Diabetes medication

FAQs on Metdot 1000mg Tablet SR

Individuals with type 2 diabetes exhibit impaired responsiveness to their own insulin production. This results in elevated blood glucose. Metdot 1000mg Tablet SR employs multiple mechanisms to lower these elevated blood sugar levels. Specifically, it reduces hepatic glucose production, diminishes intestinal glucose absorption postprandially, and enhances insulin sensitivity in bodily tissues. Consequently, glucose uptake from the bloodstream is improved, and the body's natural insulin response is optimized.
Metdot 1000mg sustained-release tablets have demonstrated weight reduction benefits in overweight and obese patients. This effect may also be observed, albeit less significantly, in overweight or obese individuals with pre-diabetes. Furthermore, weight loss can occur in those with insulin resistance or sensitivity. However, self-initiation of Metdot for weight management is strongly discouraged; physician consultation is mandatory.
Metdot 1000mg SR tablets are a primary treatment option for patients with elevated blood glucose. This medication manages blood sugar by enhancing the body's insulin response, reducing hepatic glucose production, and minimizing intestinal glucose absorption. Differing from other oral hypoglycemics, Metdot 1000mg SR tablets, when used independently, infrequently lead to hypoglycemia due to their inhibition of excessive insulin release. Beyond its glycemic control benefits, this medication also assists in managing weight increase.
Metdot 1000mg sustained-release tablets generally do not induce drowsiness and are typically well-received. Infrequently, though, Metdot 1000mg sustained-release tablets can lead to sleep disturbances or insomnia. Somnolence might indicate a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Seek medical attention if fatigue or sleepiness develops during Metdot 1000mg sustained-release tablet use.
Administer Metdot 1000mg Tablet SR orally, with or following a meal. The tablet should be swallowed whole with water; do not crush or chew. For once-daily prescriptions, take it in the morning with breakfast. Twice-daily regimens should involve one tablet with breakfast and one with dinner. Three times daily, distribute doses with breakfast, lunch, and dinner. Consuming Metdot 1000mg Tablet SR with food mitigates potential gastrointestinal side effects such as indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to their own insulin. This results in elevated blood sugar (glucose) levels. Metdot 1000mg Tablet SR works through multiple mechanisms to lower these elevated blood glucose levels. It reduces glucose synthesis in the liver, diminishes glucose intestinal absorption post-meal, and enhances insulin sensitivity in bodily tissues. This combined action facilitates improved glucose uptake from the bloodstream and optimizes the body's natural insulin response.
Metdot 1000mg SR tablets have demonstrated weight reduction benefits in overweight and obese patients. This weight loss effect may also be observed in overweight or obese individuals predisposed to diabetes. Furthermore, individuals with insulin sensitivity or resistance may experience weight loss. However, self-initiation of Metdot 1000mg SR for weight management is strongly discouraged; physician consultation is essential.
Metdot 1000mg Tablet SR is an initial treatment option for hyperglycemia. This medication manages blood glucose by enhancing insulin responsiveness, reducing hepatic glucose production, and diminishing intestinal glucose absorption. Differing from other oral hypoglycemics, Metdot 1000mg Tablet SR monotherapy infrequently leads to hypoglycemia due to its inhibition of excessive insulin release. Beyond glycemic control, it also aids in weight management.
Metdot 1000mg sustained-release tablets generally do not induce drowsiness and are typically well-tolerated. Infrequently, however, Metdot 1000mg sustained-release tablets may lead to sleep disturbances or insomnia. Somnolence can be a symptom of a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Consult your physician if fatigue or sleepiness develops during Metdot 1000mg sustained-release tablet use.
Administer Metdot 1000mg Tablet SR orally, with or following a meal. The tablet should be swallowed whole with water; avoid crushing or chewing. For once-daily regimens, morning administration with breakfast is recommended. Twice-daily prescriptions should be divided, with one dose taken in the morning and the other in the evening, concurrent with meals. Three times daily, doses should be taken with breakfast, lunch, and dinner. Consuming Metdot 1000mg Tablet SR with food minimizes potential gastrointestinal distress such as indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to their endogenous insulin. This leads to elevated blood glucose concentrations. Metdot 1000mg Tablet SR employs multiple mechanisms to lower these elevated sugar levels. It reduces hepatic glucose production, diminishes intestinal glucose absorption postprandially, and enhances insulin sensitivity in bodily tissues. This combined action facilitates improved glucose uptake from the bloodstream and augments the body's natural insulin response.
Metdot 1000mg SR tablets have demonstrated weight reduction in overweight and obese patients. This effect may also be observed, albeit modestly, in overweight and obese individuals predisposed to diabetes. Furthermore, weight loss can occur in those with insulin sensitivity or resistance. However, self-initiation of Metdot 1000mg SR for weight management is inadvisable; physician consultation is necessary.
Metdot 1000mg Tablet SR is an initial treatment option for hyperglycemia. This medication manages blood glucose levels by enhancing insulin sensitivity, reducing hepatic glucose production, and limiting intestinal glucose absorption. Differing from other oral hypoglycemics, Metdot 1000mg Tablet SR monotherapy infrequently results in hypoglycemia due to its inhibition of excessive insulin release. Beyond glycemic control, this medicine also aids in weight management.
Metdot 1000mg extended-release tablets generally don't induce drowsiness and are typically well-tolerated. Infrequently, though, Metdot 1000mg extended-release tablets can lead to sleep disturbances and insomnia. Drowsiness can be a symptom of a severe adverse reaction known as lactic acidosis, especially in individuals with impaired kidney function. Consult your physician if fatigue or sleepiness develops during Metdot 1000mg extended-release tablet use.
Administer Metdot 1000mg sustained-release tablets with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily regimens, consume the tablet in the morning with breakfast. Twice-daily prescriptions should be divided, one with breakfast and the other with dinner. Three times daily, distribute doses with breakfast, lunch, and dinner. Taking Metdot 1000mg SR with food mitigates potential gastrointestinal distress, such as indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Metdot 1000mg Tablet SR
31
MRP 36
13% off